Alterity Therapeutics (ATHE) Change in Account Payables (2009 - 2020)

Alterity Therapeutics' Change in Account Payables history runs 9 years deep, the most recent figure standing at -$425086.2 for Q2 2020.

• In Q2 2020, Change in Account Payables fell 191.54% year-over-year to -$425086.2; the TTM figure through Jun 2020 stood at $4.7 million (up 247.47% YoY), while the FY2025 annual figure was -$1.3 million, down 280.25% from the prior year.
• Change in Account Payables was -$425086.2 for Q2 2020 at Alterity Therapeutics, down from $5.1 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $5.1 million in Q4 2019 to a low of -$3.2 million in Q4 2017.
• Historically, Change in Account Payables has averaged $26466.9 across 5 years, with a median of -$301256.3 in 2016.
• The sharpest annual moves came in 2017 and 2019: Change in Account Payables plunged 1065.61% in 2017, then surged 5175.08% in 2019.
• A 5-year view of Change in Account Payables shows it stood at -$278480.6 in 2016, then slumped by 1065.61% to -$3.2 million in 2017, then surged by 87.27% to -$413122.1 in 2018, then surged by 1327.75% to $5.1 million in 2019, then plunged by 108.38% to -$425086.2 in 2020.
• The last three Change in Account Payables figures came in at -$425086.2 (Q2 2020), $5.1 million (Q4 2019), and $464361.3 (Q2 2019), per Business Quant data.